Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. With a focus on oral, small molecule, tau self-association inhibitors, Oligomerix seeks to develop therapies for Alzheimer’s disease and other dementias that are easy to administer and cost effective, and which are expected to significantly add to newly emerging high-cost therapeutic options such as the monoclonal antibody targeted against beta-amyloid that was recently approved by the U.S. FDA. Oligomerix is headquartered at the Westchester Park Center in White Plains, New York and has lab facilities at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 2 Westchester Park Dr, White Plains,new York 10604,united States
- Phone
- (212) 568-0365
- jm****@****rix.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oligomerix.com
- Keywords
- Target discovery and validation, Drug discovery, Antibody discovery, Assay development, Pre-clinical development, Clinical development, Commercial development.
- HQ
- White Plains, New York
Oligomerix, Inc Questions
Oligomerix, Inc's helpline number is (212) 568-0365
Oligomerix, Inc's website is oligomerix.com
Oligomerix, Inc's LinkedIn profile is https://www.linkedin.com/company/oligomerix-inc
Oligomerix, Inc has
10 employees.
View email and phone details for 10
employees at Oligomerix, Inc.
Oligomerix, Inc's industry is
Biotechnology Research
Oligomerix, Inc's top competitors are
Receptos, A Wholly-Owned Subsidiary Of Celgene,
Cervomed,
Ac Immune,
Futureneuro,
Neuralstem, Inc.,
Longeveron,
Neurotrope Inc.,
Marvel Biosciences Corp.,
Zyversa Therapeutics Inc.,
Axon Neuroscience.
Oligomerix, Inc's support email address is jmoe@oligomerix.com
Oligomerix, Inc's categories are Biotechnology Research
Oligomerix, Inc's founding year is 2006
